Free Trial
NASDAQ:ABVC

ABVC BioPharma (ABVC) Stock Price, News & Analysis

ABVC BioPharma logo
$3.03 -0.07 (-2.26%)
Closing price 07/3/2025 03:40 PM Eastern
Extended Trading
$3.08 +0.05 (+1.62%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ABVC BioPharma Stock (NASDAQ:ABVC)

Key Stats

Today's Range
$2.80
$3.12
50-Day Range
$1.00
$3.10
52-Week Range
$0.40
$3.12
Volume
662,074 shs
Average Volume
328,517 shs
Market Capitalization
$51.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ABVC BioPharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

ABVC MarketRank™: 

ABVC BioPharma scored higher than 13% of companies evaluated by MarketBeat, and ranked 868th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for ABVC BioPharma.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ABVC BioPharma is -23.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ABVC BioPharma is -23.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ABVC BioPharma has a P/B Ratio of 50.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about ABVC BioPharma's valuation and earnings.
  • Percentage of Shares Shorted

    3.49% of the float of ABVC BioPharma has been sold short.
  • Short Interest Ratio / Days to Cover

    ABVC BioPharma has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ABVC BioPharma has recently increased by 12.54%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    ABVC BioPharma does not currently pay a dividend.

  • Dividend Growth

    ABVC BioPharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.49% of the float of ABVC BioPharma has been sold short.
  • Short Interest Ratio / Days to Cover

    ABVC BioPharma has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ABVC BioPharma has recently increased by 12.54%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    ABVC BioPharma has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for ABVC BioPharma this week, compared to 0 articles on an average week.
  • Search Interest

    3 people have searched for ABVC on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ABVC BioPharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.10% of the stock of ABVC BioPharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 11.38% of the stock of ABVC BioPharma is held by institutions.

  • Read more about ABVC BioPharma's insider trading history.
Receive ABVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter.

ABVC Stock News Headlines

ABVC BioPharma Inc Price vs Fair Value - Morningstar
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

ABVC Stock Analysis - Frequently Asked Questions

ABVC BioPharma's stock was trading at $0.59 at the beginning of 2025. Since then, ABVC shares have increased by 413.6% and is now trading at $3.03.

ABVC BioPharma, Inc. (NASDAQ:ABVC) released its quarterly earnings results on Wednesday, April, 30th. The company reported ($0.06) earnings per share for the quarter. ABVC BioPharma had a negative net margin of 963.46% and a negative trailing twelve-month return on equity of 29.62%.

ABVC BioPharma's stock reverse split before market open on Tuesday, July 25th 2023.The 1-10 reverse split was announced on Tuesday, July 25th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

ABVC BioPharma (ABVC) raised $7 million in an initial public offering on Tuesday, August 3rd 2021. The company issued 1,100,000 shares at a price of $6.25 per share.

Shares of ABVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ABVC BioPharma investors own include Meta Platforms (META), NIO (NIO), ObsEva (OBSV), Tesla (TSLA), Alibaba Group (BABA), ChargePoint (CHPT) and Walt Disney (DIS).

Company Calendar

Last Earnings
4/30/2025
Today
7/06/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ABVC
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.90 million
Net Margins
-963.46%
Pretax Margin
-666.53%

Debt

Sales & Book Value

Annual Sales
$508.38 thousand
Price / Cash Flow
N/A
Book Value
$0.06 per share
Price / Book
50.50

Miscellaneous

Free Float
14,078,000
Market Cap
$51.46 million
Optionable
Not Optionable
Beta
0.37
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ABVC) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners